Cargando…
Active surveillance in prostate cancer management: where do we stand now?
Prostate cancer (PCa) is the most common cancer in men, with a steadily rising incidence, affecting on average one in six men during their lifetime. The increase in morbidity is related to the increasing overall life expectancy, prostate-specific antigen testing, implementation of new molecular mark...
Autores principales: | Dragan, Jędrzej, Kania, Jagoda, Salagierski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130493/ https://www.ncbi.nlm.nih.gov/pubmed/34025851 http://dx.doi.org/10.5114/aoms.2019.85252 |
Ejemplares similares
-
Nature and nurture in neuropsychiatric genetics: where do we stand?
por: Dick, Danielle M., et al.
Publicado: (2010) -
Prediction of treatment outcomes in psychiatry—where do we stand ?
por: McMahon, Francis J.
Publicado: (2014) -
The genetic patterns of bladder cancer. Where do we stand now?
por: Salagierski, Maciej
Publicado: (2013) -
The impact of the digital revolution
on human brain and behavior: where
do we
stand?
por: Korte, Martin
Publicado: (2020) -
Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021)